SIMILAR PATTERNS OF AMINO ACIDS FOR 4KUK_A_RBFA201
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1as4 | ANTICHYMOTRYPSIN (Homo sapiens) |
PF00079(Serpin) | 5 | ASN A 104ASN B 381ASN A 30LEU A 55ILE A 188 | None | 1.49A | 4kukA-1as4A:undetectable | 4kukA-1as4A:17.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ji6 | PESTICIDIAL CRYSTALPROTEIN CRY3BB (Bacillusthuringiensis) |
PF00555(Endotoxin_M)PF03944(Endotoxin_C)PF03945(Endotoxin_N) | 5 | VAL A 264GLN A 485LEU A 312ILE A 491GLN A 316 | None | 1.48A | 4kukA-1ji6A:undetectable | 4kukA-1ji6A:12.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jn1 | 2C-METHYL-D-ERYTHRITOL2,4-CYCLODIPHOSPHATESYNTHASE (Haemophilusinfluenzae) |
PF02542(YgbB) | 5 | VAL A 95CYH A 123GLN A 122LEU A 78ILE A 49 | None | 1.37A | 4kukA-1jn1A:undetectable | 4kukA-1jn1A:25.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jnu | PHY3 PROTEIN (Adiantumcapillus-veneris) |
PF13426(PAS_9) | 5 | ASN A 965CYH A 966ASN A1008ILE A 982GLN A1029 | FMN A1033 (-3.2A)FMN A1033 (-1.8A)FMN A1033 (-4.1A)FMN A1033 (-4.3A)FMN A1033 (-4.2A) | 1.26A | 4kukA-1jnuA:19.4 | 4kukA-1jnuA:34.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jnu | PHY3 PROTEIN (Adiantumcapillus-veneris) |
PF13426(PAS_9) | 9 | VAL A 932ASN A 941ASN A 965CYH A 966ARG A 967GLN A 970ASN A 998ASN A1008GLN A1029 | NoneFMN A1033 ( 4.4A)FMN A1033 (-3.2A)FMN A1033 (-1.8A)FMN A1033 (-3.6A)FMN A1033 (-3.1A)FMN A1033 (-3.2A)FMN A1033 (-4.1A)FMN A1033 (-4.2A) | 0.57A | 4kukA-1jnuA:19.4 | 4kukA-1jnuA:34.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jnu | PHY3 PROTEIN (Adiantumcapillus-veneris) |
PF13426(PAS_9) | 5 | VAL A 932ASN A 941ASN A 965CYH A 966ASN A 998 | NoneFMN A1033 ( 4.4A)FMN A1033 (-3.2A)FMN A1033 (-1.8A)FMN A1033 (-3.2A) | 1.33A | 4kukA-1jnuA:19.4 | 4kukA-1jnuA:34.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n9l | PUTATIVE BLUE LIGHTRECEPTOR (Chlamydomonasreinhardtii) |
PF13426(PAS_9) | 5 | CYH A 57ASN A 99LEU A 101ILE A 73GLN A 120 | FMN A 500 (-3.4A)FMN A 500 (-3.9A)FMN A 500 (-4.1A)FMN A 500 ( 4.2A)FMN A 500 (-3.7A) | 1.44A | 4kukA-1n9lA:18.9 | 4kukA-1n9lA:36.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n9l | PUTATIVE BLUE LIGHTRECEPTOR (Chlamydomonasreinhardtii) |
PF13426(PAS_9) | 9 | VAL A 23ASN A 56CYH A 57ARG A 58GLN A 61ASN A 89ASN A 99LEU A 101GLN A 120 | NoneFMN A 500 (-2.9A)FMN A 500 (-3.4A)FMN A 500 (-4.0A)FMN A 500 (-3.3A)FMN A 500 (-3.0A)FMN A 500 (-3.9A)FMN A 500 (-4.1A)FMN A 500 (-3.7A) | 0.38A | 4kukA-1n9lA:18.9 | 4kukA-1n9lA:36.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nlr | ENDO-1,4-BETA-GLUCANASE (Streptomyceslividans) |
PF01670(Glyco_hydro_12) | 5 | SER A 102ASN A 100GLN A 30ASN A 21GLN A 20 | MHO A 122 ( 4.1A)MHO A 122 ( 4.7A)NoneNoneNone | 1.31A | 4kukA-1nlrA:undetectable | 4kukA-1nlrA:19.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vko | INOSITOL-3-PHOSPHATESYNTHASE (Caenorhabditiselegans) |
PF01658(Inos-1-P_synth)PF07994(NAD_binding_5) | 5 | SER A 364ASN A 238ASN A 351LEU A 352ILE A 392 | NoneNAD A 601 (-3.5A)NoneNoneNone | 1.47A | 4kukA-1vkoA:undetectable | 4kukA-1vkoA:15.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xv9 | ORPHAN NUCLEARRECEPTOR NR1I3 (Homo sapiens) |
PF00104(Hormone_recep) | 5 | VAL B 172CYH B 202ASN B 165LEU B 343ILE B 346 | None | 1.46A | 4kukA-1xv9B:undetectable | 4kukA-1xv9B:19.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2btw | ALR0975 PROTEIN (Nostoc sp. PCC7120) |
PF05023(Phytochelatin) | 5 | VAL A 139SER A 238ASN A 165ASN A 159GLN A 155 | None | 1.46A | 4kukA-2btwA:undetectable | 4kukA-2btwA:20.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ek8 | AMINOPEPTIDASE (Aneurinibacillussp. AM-1) |
PF02225(PA)PF04389(Peptidase_M28) | 5 | SER A 243ASN A 239LEU A 360ILE A 362GLN A 299 | None | 1.39A | 4kukA-2ek8A:undetectable | 4kukA-2ek8A:15.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i0z | NAD(FAD)-UTILIZINGDEHYDROGENASES (Bacillus cereus) |
PF03486(HI0933_like) | 5 | VAL A 112ASN A 50CYH A 49LEU A 405ILE A 83 | None CL A 424 (-4.8A)NoneNoneNone | 1.43A | 4kukA-2i0zA:undetectable | 4kukA-2i0zA:15.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mwg | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF01740(STAS)PF13426(PAS_9) | 6 | VAL A 28ASN A 37ASN A 104LEU A 106ILE A 108GLN A 123 | NoneFMN A 900 ( 4.9A)FMN A 900 (-3.9A)FMN A 900 (-4.3A)FMN A 900 ( 4.1A)FMN A 900 (-4.2A) | 0.77A | 4kukA-2mwgA:14.8 | 4kukA-2mwgA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mwg | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF01740(STAS)PF13426(PAS_9) | 6 | VAL A 28ASN A 61CYH A 62ASN A 104LEU A 106ILE A 108 | NoneFMN A 900 (-2.0A)FMN A 900 (-3.3A)FMN A 900 (-3.9A)FMN A 900 (-4.3A)FMN A 900 ( 4.1A) | 1.27A | 4kukA-2mwgA:14.8 | 4kukA-2mwgA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mwg | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF01740(STAS)PF13426(PAS_9) | 9 | VAL A 28ASN A 61CYH A 62GLN A 66ASN A 94ASN A 104LEU A 106ILE A 108GLN A 123 | NoneFMN A 900 (-2.0A)FMN A 900 (-3.3A)FMN A 900 (-2.6A)FMN A 900 (-2.9A)FMN A 900 (-3.9A)FMN A 900 (-4.3A)FMN A 900 ( 4.1A)FMN A 900 (-4.2A) | 0.85A | 4kukA-2mwgA:14.8 | 4kukA-2mwgA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mwg | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF01740(STAS)PF13426(PAS_9) | 6 | VAL A 28CYH A 62ARG A 63ASN A 94ASN A 104GLN A 123 | NoneFMN A 900 (-3.3A)FMN A 900 (-4.9A)FMN A 900 (-2.9A)FMN A 900 (-3.9A)FMN A 900 (-4.2A) | 1.18A | 4kukA-2mwgA:14.8 | 4kukA-2mwgA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2paa | PHOSPHOGLYCERATEKINASE, TESTISSPECIFIC (Mus musculus) |
PF00162(PGK) | 5 | VAL A 58SER A 114CYH A 107GLN A 105LEU A 95 | None | 1.25A | 4kukA-2paaA:undetectable | 4kukA-2paaA:15.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pr5 | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF13426(PAS_9) | 11 | VAL A 28ASN A 37ASN A 61CYH A 62ARG A 63GLN A 66ASN A 94ASN A 104LEU A 106ILE A 108GLN A 123 | NoneFMN A 500 (-3.8A)FMN A 500 (-3.2A)FMN A 500 (-3.5A)FMN A 500 (-3.8A)FMN A 500 (-3.1A)FMN A 500 (-3.1A)FMN A 500 (-3.7A)FMN A 500 (-4.1A)FMN A 500 (-4.2A)FMN A 500 (-3.9A) | 0.38A | 4kukA-2pr5A:17.1 | 4kukA-2pr5A:33.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pr5 | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF13426(PAS_9) | 5 | VAL A 28ASN A 61LEU A 106ILE A 108GLN A 123 | NoneFMN A 500 (-3.2A)FMN A 500 (-4.1A)FMN A 500 (-4.2A)FMN A 500 (-3.9A) | 1.17A | 4kukA-2pr5A:17.1 | 4kukA-2pr5A:33.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wkp | NPH1-1, RAS-RELATEDC3 BOTULINUM TOXINSUBSTRATE 1 (Avena sativa;Homo sapiens) |
PF00071(Ras)PF13426(PAS_9) | 5 | ASN A 449CYH A 450ASN A 492ILE A 466GLN A 513 | FMN A1725 (-3.0A)FMN A1725 (-3.4A)FMN A1725 (-3.8A)FMN A1725 (-4.2A)FMN A1725 (-3.8A) | 1.47A | 4kukA-2wkpA:18.0 | 4kukA-2wkpA:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wkp | NPH1-1, RAS-RELATEDC3 BOTULINUM TOXINSUBSTRATE 1 (Avena sativa;Homo sapiens) |
PF00071(Ras)PF13426(PAS_9) | 8 | VAL A 416ASN A 425ASN A 449ARG A 451GLN A 454ASN A 482ASN A 492GLN A 513 | NoneFMN A1725 (-3.8A)FMN A1725 (-3.0A)FMN A1725 (-3.8A)FMN A1725 (-3.1A)FMN A1725 (-3.0A)FMN A1725 (-3.8A)FMN A1725 (-3.8A) | 0.43A | 4kukA-2wkpA:18.0 | 4kukA-2wkpA:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wkp | NPH1-1, RAS-RELATEDC3 BOTULINUM TOXINSUBSTRATE 1 (Avena sativa;Homo sapiens) |
PF00071(Ras)PF13426(PAS_9) | 7 | VAL A 416ASN A 449CYH A 450ARG A 451GLN A 454ASN A 492GLN A 513 | NoneFMN A1725 (-3.0A)FMN A1725 (-3.4A)FMN A1725 (-3.8A)FMN A1725 (-3.1A)FMN A1725 (-3.8A)FMN A1725 (-3.8A) | 0.83A | 4kukA-2wkpA:18.0 | 4kukA-2wkpA:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wkp | NPH1-1, RAS-RELATEDC3 BOTULINUM TOXINSUBSTRATE 1 (Avena sativa;Homo sapiens) |
PF00071(Ras)PF13426(PAS_9) | 5 | VAL A 416ASN A 449CYH A 450ARG A 451LEU A 496 | NoneFMN A1725 (-3.0A)FMN A1725 (-3.4A)FMN A1725 (-3.8A)FMN A1725 (-4.8A) | 1.16A | 4kukA-2wkpA:18.0 | 4kukA-2wkpA:22.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z6c | PHOTOTROPIN-1 (Arabidopsisthaliana) |
PF13426(PAS_9) | 8 | SER A 202ASN A 233ARG A 235GLN A 238ASN A 266ASN A 276LEU A 278ILE A 280 | FMN A 500 (-3.6A)FMN A 500 (-3.0A)FMN A 500 (-3.9A)FMN A 500 (-3.0A)FMN A 500 (-3.0A)FMN A 500 (-3.6A)FMN A 500 (-4.3A)FMN A 500 ( 4.6A) | 0.69A | 4kukA-2z6cA:16.6 | 4kukA-2z6cA:38.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z6c | PHOTOTROPIN-1 (Arabidopsisthaliana) |
PF13426(PAS_9) | 10 | VAL A 200ASN A 233CYH A 234ARG A 235GLN A 238ASN A 266ASN A 276LEU A 278ILE A 280GLN A 297 | NoneFMN A 500 (-3.0A)FMN A 500 (-3.4A)FMN A 500 (-3.9A)FMN A 500 (-3.0A)FMN A 500 (-3.0A)FMN A 500 (-3.6A)FMN A 500 (-4.3A)FMN A 500 ( 4.6A)FMN A 500 (-3.6A) | 0.52A | 4kukA-2z6cA:16.6 | 4kukA-2z6cA:38.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z6c | PHOTOTROPIN-1 (Arabidopsisthaliana) |
PF13426(PAS_9) | 5 | VAL A 200ASN A 233LEU A 278ILE A 280GLN A 297 | NoneFMN A 500 (-3.0A)FMN A 500 (-4.3A)FMN A 500 ( 4.6A)FMN A 500 (-3.6A) | 1.26A | 4kukA-2z6cA:16.6 | 4kukA-2z6cA:38.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z6d | PHOTOTROPIN-2 (Arabidopsisthaliana) |
PF13426(PAS_9) | 8 | SER A 138ASN A 169ARG A 171GLN A 174ASN A 202ASN A 212LEU A 214GLN A 233 | FMN A 500 (-3.6A)FMN A 500 (-3.0A)FMN A 500 (-3.7A)FMN A 500 (-3.0A)FMN A 500 (-3.1A)FMN A 500 (-3.7A)FMN A 500 (-4.3A)FMN A 500 (-3.8A) | 0.67A | 4kukA-2z6dA:19.0 | 4kukA-2z6dA:36.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z6d | PHOTOTROPIN-2 (Arabidopsisthaliana) |
PF13426(PAS_9) | 9 | VAL A 136ASN A 169CYH A 170ARG A 171GLN A 174ASN A 202ASN A 212LEU A 214GLN A 233 | NoneFMN A 500 (-3.0A)FMN A 500 (-3.5A)FMN A 500 (-3.7A)FMN A 500 (-3.0A)FMN A 500 (-3.1A)FMN A 500 (-3.7A)FMN A 500 (-4.3A)FMN A 500 (-3.8A) | 0.28A | 4kukA-2z6dA:19.0 | 4kukA-2z6dA:36.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zle | PROTEASE DO (Escherichiacoli) |
PF00595(PDZ)PF13365(Trypsin_2) | 5 | VAL A 145ASN A 152ASN A 180LEU A 169ILE A 177 | None | 1.47A | 4kukA-2zleA:undetectable | 4kukA-2zleA:16.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zyl | POSSIBLEOXIDOREDUCTASE (Mycobacteriumtuberculosis) |
PF00355(Rieske) | 5 | ASN A 257GLN A 204ASN A 195LEU A 329ILE A 173 | None | 1.27A | 4kukA-2zylA:undetectable | 4kukA-2zylA:16.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ayt | PUTATIVEUNCHARACTERIZEDPROTEIN TTHB071 (Thermusthermophilus) |
PF01261(AP_endonuc_2) | 5 | VAL A 168SER A 170ASN A 137ASN A 189LEU A 206 | None | 1.10A | 4kukA-3aytA:undetectable | 4kukA-3aytA:21.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ezo | MALONYL COA-ACYLCARRIER PROTEINTRANSACYLASE (Burkholderiapseudomallei) |
PF00698(Acyl_transf_1) | 5 | ARG A 112ASN A 54LEU A 53ILE A 45GLN A 12 | None | 1.41A | 4kukA-3ezoA:undetectable | 4kukA-3ezoA:17.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gm8 | GLYCOSIDE HYDROLASEFAMILY 2, CANDIDATEBETA-GLYCOSIDASE (Bacteroidesvulgatus) |
PF00703(Glyco_hydro_2)PF02836(Glyco_hydro_2_C)PF02837(Glyco_hydro_2_N)PF16355(DUF4982) | 5 | SER A 713ASN A 714GLN A 788LEU A 755ILE A 812 | None | 1.28A | 4kukA-3gm8A:undetectable | 4kukA-3gm8A:11.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3htk | E3 SUMO-PROTEINLIGASE MMS21 (Saccharomycescerevisiae) |
PF11789(zf-Nse) | 5 | VAL C 236SER C 197ASN C 201GLN C 165ASN C 140 | None | 1.36A | 4kukA-3htkC:undetectable | 4kukA-3htkC:20.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3oja | ANOPHELESPLASMODIUM-RESPONSIVE LEUCINE-RICHREPEAT PROTEIN 1 (Anophelesgambiae) |
PF13855(LRR_8) | 5 | ARG B 354ASN B 348ASN B 329LEU B 310ILE B 289 | None | 1.48A | 4kukA-3ojaB:undetectable | 4kukA-3ojaB:15.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p7n | SENSOR HISTIDINEKINASE (Erythrobacterlitoralis) |
PF00196(GerE)PF13426(PAS_9) | 5 | ASN A 74CYH A 75ASN A 117ILE A 91GLN A 138 | FMN A 500 (-3.1A)FMN A 500 (-3.3A)FMN A 500 (-4.1A)FMN A 500 (-3.9A)FMN A 500 (-3.9A) | 1.12A | 4kukA-3p7nA:19.3 | 4kukA-3p7nA:29.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p7n | SENSOR HISTIDINEKINASE (Erythrobacterlitoralis) |
PF00196(GerE)PF13426(PAS_9) | 9 | VAL A 41SER A 43ASN A 50ASN A 74CYH A 75ARG A 76ASN A 107ASN A 117GLN A 138 | NoneFMN A 500 (-3.4A)FMN A 500 (-3.9A)FMN A 500 (-3.1A)FMN A 500 (-3.3A)FMN A 500 (-3.8A)FMN A 500 (-3.1A)FMN A 500 (-4.1A)FMN A 500 (-3.9A) | 0.46A | 4kukA-3p7nA:19.3 | 4kukA-3p7nA:29.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p7n | SENSOR HISTIDINEKINASE (Erythrobacterlitoralis) |
PF00196(GerE)PF13426(PAS_9) | 6 | VAL A 41SER A 43ASN A 50ASN A 74CYH A 75ASN A 107 | NoneFMN A 500 (-3.4A)FMN A 500 (-3.9A)FMN A 500 (-3.1A)FMN A 500 (-3.3A)FMN A 500 (-3.1A) | 1.21A | 4kukA-3p7nA:19.3 | 4kukA-3p7nA:29.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p7n | SENSOR HISTIDINEKINASE (Erythrobacterlitoralis) |
PF00196(GerE)PF13426(PAS_9) | 5 | VAL A 121ASN A 117ASN A 107ASN A 74LEU A 52 | FMN A 500 (-4.5A)FMN A 500 (-4.1A)FMN A 500 (-3.1A)FMN A 500 (-3.1A)None | 1.49A | 4kukA-3p7nA:19.3 | 4kukA-3p7nA:29.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qp8 | CVIR TRANSCRIPTIONALREGULATOR (Chromobacteriumviolaceum) |
PF03472(Autoind_bind) | 5 | VAL A 109ARG A 101GLN A 68LEU A 104ILE A 153 | None | 1.18A | 4kukA-3qp8A:2.5 | 4kukA-3qp8A:24.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3rh8 | VIVID PAS PROTEINVVD (Neurosporacrassa) |
PF13426(PAS_9) | 5 | ARG B 109GLN B 112ASN B 151ASN B 161ILE B 74 | FAD B5201 (-4.3A)FAD B5201 (-3.1A)FAD B5201 (-3.0A)FAD B5201 (-3.7A)FAD B5201 (-4.9A) | 1.37A | 4kukA-3rh8B:17.5 | 4kukA-3rh8B:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3rh8 | VIVID PAS PROTEINVVD (Neurosporacrassa) |
PF13426(PAS_9) | 6 | ARG B 124ASN B 151ASN B 161LEU B 163ILE B 165GLN B 182 | FAD B5201 (-3.4A)FAD B5201 (-3.0A)FAD B5201 (-3.7A)FAD B5201 (-3.8A)FAD B5201 ( 4.1A)FAD B5201 (-4.1A) | 1.37A | 4kukA-3rh8B:17.5 | 4kukA-3rh8B:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3rh8 | VIVID PAS PROTEINVVD (Neurosporacrassa) |
PF13426(PAS_9) | 9 | ASN B 107CYH B 108ARG B 109GLN B 112ASN B 151ASN B 161LEU B 163ILE B 165GLN B 182 | FAD B5201 (-3.2A)FAD B5201 (-1.8A)FAD B5201 (-4.3A)FAD B5201 (-3.1A)FAD B5201 (-3.0A)FAD B5201 (-3.7A)FAD B5201 (-3.8A)FAD B5201 ( 4.1A)FAD B5201 (-4.1A) | 0.57A | 4kukA-3rh8B:17.5 | 4kukA-3rh8B:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3rh8 | VIVID PAS PROTEINVVD (Neurosporacrassa) |
PF13426(PAS_9) | 6 | SER B 178GLN B 112ASN B 151ASN B 161LEU B 163GLN B 182 | FAD B5201 (-3.3A)FAD B5201 (-3.1A)FAD B5201 (-3.0A)FAD B5201 (-3.7A)FAD B5201 (-3.8A)FAD B5201 (-4.1A) | 0.93A | 4kukA-3rh8B:17.5 | 4kukA-3rh8B:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t50 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE (Brucellamelitensis) |
PF13426(PAS_9) | 9 | ASN A 44ASN A 68ARG A 70GLN A 73ASN A 101ASN A 111LEU A 113ILE A 115GLN A 132 | FMN A 200 (-4.0A)FMN A 200 (-3.1A)FMN A 200 (-3.9A)FMN A 200 (-3.1A)FMN A 200 (-3.1A)FMN A 200 (-3.8A)FMN A 200 (-4.3A)FMN A 200 (-4.3A)FMN A 200 (-3.9A) | 0.53A | 4kukA-3t50A:19.5 | 4kukA-3t50A:39.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t50 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE (Brucellamelitensis) |
PF13426(PAS_9) | 8 | ASN A 68CYH A 69ARG A 70GLN A 73ASN A 111LEU A 113ILE A 115GLN A 132 | FMN A 200 (-3.1A)FMN A 200 (-3.4A)FMN A 200 (-3.9A)FMN A 200 (-3.1A)FMN A 200 (-3.8A)FMN A 200 (-4.3A)FMN A 200 (-4.3A)FMN A 200 (-3.9A) | 0.81A | 4kukA-3t50A:19.5 | 4kukA-3t50A:39.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t50 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE (Brucellamelitensis) |
PF13426(PAS_9) | 5 | GLN A 73ASN A 101ASN A 111LEU A 113ILE A 95 | FMN A 200 (-3.1A)FMN A 200 (-3.1A)FMN A 200 (-3.8A)FMN A 200 (-4.3A)None | 1.12A | 4kukA-3t50A:19.5 | 4kukA-3t50A:39.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ue6 | AUREOCHROME1 (Vaucheriafrigida) |
PF13426(PAS_9) | 8 | VAL A 220ASN A 229ASN A 253ARG A 255GLN A 258ASN A 286ASN A 296GLN A 317 | NoneFMN A 500 (-3.9A)FMN A 500 (-3.1A)FMN A 500 (-3.6A)FMN A 500 (-3.1A)FMN A 500 (-3.3A)FMN A 500 (-4.3A)FMN A 500 (-4.1A) | 0.43A | 4kukA-3ue6A:19.3 | 4kukA-3ue6A:35.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ue6 | AUREOCHROME1 (Vaucheriafrigida) |
PF13426(PAS_9) | 7 | VAL A 220ASN A 253CYH A 254ARG A 255GLN A 258ASN A 296GLN A 317 | NoneFMN A 500 (-3.1A)FMN A 500 (-3.5A)FMN A 500 (-3.6A)FMN A 500 (-3.1A)FMN A 500 (-4.3A)FMN A 500 (-4.1A) | 0.72A | 4kukA-3ue6A:19.3 | 4kukA-3ue6A:35.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zmr | CELLULASE (GLYCOSYLHYDROLASE FAMILY 5) (Bacteroidesovatus) |
PF00150(Cellulase)PF13004(BACON) | 5 | VAL A 110SER A 82CYH A 80LEU A 52ILE A 63 | None | 1.45A | 4kukA-3zmrA:undetectable | 4kukA-3zmrA:15.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ees | PHOTOTROPIN-2 (Arabidopsisthaliana) |
PF13426(PAS_9) | 9 | VAL A 392ASN A 401ASN A 425ARG A 427GLN A 430ASN A 458ASN A 468LEU A 470GLN A 489 | NoneFMN A1001 (-3.8A)FMN A1001 (-3.0A)FMN A1001 (-3.8A)FMN A1001 (-3.2A)FMN A1001 (-3.0A)FMN A1001 (-3.9A)FMN A1001 (-4.2A)FMN A1001 (-3.9A) | 0.32A | 4kukA-4eesA:20.2 | 4kukA-4eesA:34.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gcz | BLUE-LIGHTPHOTORECEPTOR,SENSOR PROTEIN FIXL (Bacillussubtilis;Bradyrhizobiumdiazoefficiens) |
PF00512(HisKA)PF02518(HATPase_c)PF13426(PAS_9) | 5 | ASN A 61CYH A 62ASN A 104LEU A 106ILE A 78 | FMN A 401 (-3.1A)FMN A 401 (-3.3A)FMN A 401 (-3.7A)FMN A 401 (-4.3A)FMN A 401 (-4.1A) | 1.44A | 4kukA-4gczA:17.7 | 4kukA-4gczA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gcz | BLUE-LIGHTPHOTORECEPTOR,SENSOR PROTEIN FIXL (Bacillussubtilis;Bradyrhizobiumdiazoefficiens) |
PF00512(HisKA)PF02518(HATPase_c)PF13426(PAS_9) | 10 | VAL A 28ASN A 37ASN A 61ARG A 63GLN A 66ASN A 94ASN A 104LEU A 106ILE A 108GLN A 123 | NoneFMN A 401 (-4.1A)FMN A 401 (-3.1A)FMN A 401 (-3.9A)FMN A 401 (-3.2A)FMN A 401 (-3.1A)FMN A 401 (-3.7A)FMN A 401 (-4.3A)FMN A 401 (-4.2A)FMN A 401 (-3.8A) | 0.33A | 4kukA-4gczA:17.7 | 4kukA-4gczA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gcz | BLUE-LIGHTPHOTORECEPTOR,SENSOR PROTEIN FIXL (Bacillussubtilis;Bradyrhizobiumdiazoefficiens) |
PF00512(HisKA)PF02518(HATPase_c)PF13426(PAS_9) | 10 | VAL A 28ASN A 61CYH A 62ARG A 63GLN A 66ASN A 94ASN A 104LEU A 106ILE A 108GLN A 123 | NoneFMN A 401 (-3.1A)FMN A 401 (-3.3A)FMN A 401 (-3.9A)FMN A 401 (-3.2A)FMN A 401 (-3.1A)FMN A 401 (-3.7A)FMN A 401 (-4.3A)FMN A 401 (-4.2A)FMN A 401 (-3.8A) | 0.62A | 4kukA-4gczA:17.7 | 4kukA-4gczA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gcz | BLUE-LIGHTPHOTORECEPTOR,SENSOR PROTEIN FIXL (Bacillussubtilis;Bradyrhizobiumdiazoefficiens) |
PF00512(HisKA)PF02518(HATPase_c)PF13426(PAS_9) | 5 | VAL A 28ASN A 61LEU A 106ILE A 108GLN A 123 | NoneFMN A 401 (-3.1A)FMN A 401 (-4.3A)FMN A 401 (-4.2A)FMN A 401 (-3.8A) | 1.22A | 4kukA-4gczA:17.7 | 4kukA-4gczA:17.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hhd | PHOTOTROPIN-1 (Arabidopsisthaliana) |
PF13426(PAS_9) | 8 | VAL A 478ASN A 487ASN A 511ARG A 513GLN A 516ASN A 544ASN A 554GLN A 575 | NoneFMN A 701 (-3.7A)FMN A 701 (-2.9A)FMN A 701 (-2.6A)FMN A 701 (-3.3A)FMN A 701 (-2.8A)FMN A 701 (-3.8A)FMN A 701 (-3.6A) | 0.57A | 4kukA-4hhdA:19.2 | 4kukA-4hhdA:32.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hhd | PHOTOTROPIN-1 (Arabidopsisthaliana) |
PF13426(PAS_9) | 8 | VAL A 478ASN A 487ASN A 511CYH A 512ARG A 513GLN A 516ASN A 554GLN A 575 | NoneFMN A 701 (-3.7A)FMN A 701 (-2.9A)FMN A 701 (-3.7A)FMN A 701 (-2.6A)FMN A 701 (-3.3A)FMN A 701 (-3.8A)FMN A 701 (-3.6A) | 0.81A | 4kukA-4hhdA:19.2 | 4kukA-4hhdA:32.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hj3 | LOV PROTEIN (Rhodobactersphaeroides) |
PF13426(PAS_9) | 8 | ASN A 54CYH A 55ARG A 56GLN A 59ASN A 87ASN A 97LEU A 99GLN A 118 | FMN A 201 (-3.1A)FMN A 201 (-3.7A)FMN A 201 (-3.4A)FMN A 201 (-3.6A)FMN A 201 (-2.9A)FMN A 201 (-3.8A)FMN A 201 (-4.4A)FMN A 201 (-3.8A) | 0.73A | 4kukA-4hj3A:15.0 | 4kukA-4hj3A:29.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homo sapiens) |
PF00587(tRNA-synt_2b)PF03129(HGTP_anticodon) | 5 | ASN A 704ARG A 724GLN A 702LEU A 365ILE A 385 | None | 1.11A | 4kukA-4hwtA:undetectable | 4kukA-4hwtA:18.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o5j | UNCHARACTERIZEDPROTEIN (Helicobacterpylori) |
no annotation | 5 | SER A 190ASN A 194LEU A 94ILE A 90GLN A 159 | NoneNoneNoneNoneGOL A 503 (-4.1A) | 1.27A | 4kukA-4o5jA:undetectable | 4kukA-4o5jA:13.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qdf | 3-KETOSTEROID9ALPHA-HYDROXYLASEOXYGENASE (Rhodococcusrhodochrous) |
PF00355(Rieske) | 5 | ASN B 258GLN B 204ASN B 195LEU B 330ILE B 173 | 30Q B 403 ( 4.7A)30Q B 403 (-4.0A)NoneNoneNone | 1.24A | 4kukA-4qdfB:undetectable | 4kukA-4qdfB:15.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF13426(PAS_9) | 8 | ASN A 54CYH A 55ARG A 56GLN A 59ASN A 87ASN A 97LEU A 99GLN A 118 | RBF A 201 (-2.6A)RBF A 201 (-3.3A)RBF A 201 (-3.7A)RBF A 201 (-3.0A)RBF A 201 (-2.4A)RBF A 201 (-3.7A)RBF A 201 (-4.2A)RBF A 201 (-4.0A) | 0.39A | 4kukA-4r38A:18.4 | 4kukA-4r38A:36.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF07568(HisKA_2)PF13426(PAS_9)PF13581(HATPase_c_2) | 8 | ASN A 54CYH A 55ARG A 56GLN A 59ASN A 87ASN A 97LEU A 99GLN A 118 | RBF A 402 (-2.9A)RBF A 402 (-3.4A)RBF A 402 (-3.6A)RBF A 402 (-3.3A)RBF A 402 (-2.3A)RBF A 402 (-4.0A)RBF A 402 (-4.3A)RBF A 402 (-4.3A) | 0.34A | 4kukA-4r3aA:14.6 | 4kukA-4r3aA:16.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wuj | GLYCOSIDE HYDROLASEFAMILY 15, CELLULOSESIGNALING ASSOCIATEDPROTEIN ENVOY (Trichodermareesei) |
PF13426(PAS_9) | 8 | ASN A 134CYH A 135ARG A 136GLN A 139ASN A 173ASN A 183ILE A 187GLN A 204 | FMN A5201 (-2.5A)FMN A5201 (-3.5A)FMN A5201 (-3.7A)FMN A5201 (-3.1A)FMN A5201 (-2.4A)FMN A5201 (-4.1A)FMN A5201 (-4.0A)FMN A5201 (-3.7A) | 0.65A | 4kukA-4wujA:16.5 | 4kukA-4wujA:35.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xmm | NUCLEOPORIN NUP120 (Saccharomycescerevisiae) |
no annotation | 5 | ASN E 94GLN E 477ASN E 480ASN E 10LEU E 12 | None | 1.38A | 4kukA-4xmmE:undetectable | 4kukA-4xmmE:8.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4y9l | PROTEIN ACDH-11,ISOFORM B (Caenorhabditiselegans) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M) | 5 | VAL A 575SER A 571ASN A 569LEU A 388ILE A 51 | None | 1.09A | 4kukA-4y9lA:undetectable | 4kukA-4y9lA:11.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a8b | PTAUREO1A LOV2DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 9 | VAL A 253ASN A 262ASN A 286ARG A 288GLN A 291ASN A 319ASN A 329ILE A 333GLN A 350 | NoneFMN A 500 (-3.8A)FMN A 500 (-3.2A)FMN A 500 (-4.1A)FMN A 500 (-3.0A)FMN A 500 (-3.0A)FMN A 500 (-4.2A)NoneFMN A 500 (-3.9A) | 0.48A | 4kukA-5a8bA:19.3 | 4kukA-5a8bA:36.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a8b | PTAUREO1A LOV2DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 8 | VAL A 253ASN A 262ASN A 286CYH A 287ARG A 288GLN A 291ILE A 333GLN A 350 | NoneFMN A 500 (-3.8A)FMN A 500 (-3.2A)FMN A 500 (-3.6A)FMN A 500 (-4.1A)FMN A 500 (-3.0A)NoneFMN A 500 (-3.9A) | 0.75A | 4kukA-5a8bA:19.3 | 4kukA-5a8bA:36.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a8b | PTAUREO1A LOV2DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 6 | VAL A 253ASN A 262ASN A 286CYH A 287ASN A 319ILE A 333 | NoneFMN A 500 (-3.8A)FMN A 500 (-3.2A)FMN A 500 (-3.6A)FMN A 500 (-3.0A)None | 1.33A | 4kukA-5a8bA:19.3 | 4kukA-5a8bA:36.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dju | NPH1-2 (Avena sativa) |
PF13426(PAS_9) | 8 | VAL A 416ASN A 425ASN A 449ARG A 451GLN A 454ASN A 482ASN A 492GLN A 513 | NoneFMN A 601 ( 3.9A)FMN A 601 ( 3.1A)FMN A 601 ( 3.8A)FMN A 601 (-3.1A)FMN A 601 (-3.1A)FMN A 601 (-3.9A)FMN A 601 (-3.8A) | 0.47A | 4kukA-5djuA:17.3 | 4kukA-5djuA:30.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dkk | LOV DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 5 | ASN A 286CYH A 287ASN A 329ILE A 303GLN A 350 | FMN A 401 (-3.0A)FMN A 401 (-3.4A)FMN A 401 (-4.1A)FMN A 401 (-4.2A)FMN A 401 (-3.8A) | 1.44A | 4kukA-5dkkA:19.4 | 4kukA-5dkkA:36.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dkk | LOV DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 9 | VAL A 253ASN A 262ASN A 286ARG A 288GLN A 291ASN A 319ASN A 329ILE A 333GLN A 350 | NoneFMN A 401 (-3.7A)FMN A 401 (-3.0A)FMN A 401 (-4.1A)FMN A 401 (-2.8A)FMN A 401 (-3.0A)FMN A 401 (-4.1A)NoneFMN A 401 (-3.8A) | 0.55A | 4kukA-5dkkA:19.4 | 4kukA-5dkkA:36.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dkk | LOV DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 9 | VAL A 253ASN A 262ASN A 286CYH A 287ARG A 288GLN A 291ASN A 329ILE A 333GLN A 350 | NoneFMN A 401 (-3.7A)FMN A 401 (-3.0A)FMN A 401 (-3.4A)FMN A 401 (-4.1A)FMN A 401 (-2.8A)FMN A 401 (-4.1A)NoneFMN A 401 (-3.8A) | 0.75A | 4kukA-5dkkA:19.4 | 4kukA-5dkkA:36.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dkk | LOV DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 6 | VAL A 253ASN A 262ASN A 286CYH A 287ASN A 319ILE A 333 | NoneFMN A 401 (-3.7A)FMN A 401 (-3.0A)FMN A 401 (-3.4A)FMN A 401 (-3.0A)None | 1.27A | 4kukA-5dkkA:19.4 | 4kukA-5dkkA:36.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hzh | RAS-RELATED C3BOTULINUM TOXINSUBSTRATE1,NPH1-1,RAS-RELATEDC3 BOTULINUM TOXINSUBSTRATE 1 (Avena sativa;Homo sapiens) |
PF00071(Ras)PF13426(PAS_9) | 8 | VAL A 63ASN A 72ASN A 96ARG A 98GLN A 101ASN A 129ASN A 139GLN A 160 | NoneFMN A 402 (-3.8A)FMN A 402 (-3.2A)FMN A 402 (-3.3A)FMN A 402 (-2.9A)FMN A 402 (-2.9A)FMN A 402 (-4.2A)FMN A 402 (-3.6A) | 0.37A | 4kukA-5hzhA:17.7 | 4kukA-5hzhA:25.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hzk | INTERSECTIN-1,NPH1-1,INTERSECTIN-1 (Avena sativa;Homo sapiens) |
PF00621(RhoGEF)PF13426(PAS_9)PF16652(PH_13) | 8 | VAL B1321ASN B1330ASN B1354ARG B1356GLN B1359ASN B1387ASN B1397GLN B1418 | NoneFMN B1801 (-4.1A)FMN B1801 (-3.0A)FMN B1801 (-3.9A)FMN B1801 (-3.0A)FMN B1801 (-3.0A)FMN B1801 (-4.2A)FMN B1801 (-3.7A) | 0.46A | 4kukA-5hzkB:17.9 | 4kukA-5hzkB:16.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hzk | INTERSECTIN-1,NPH1-1,INTERSECTIN-1 (Avena sativa;Homo sapiens) |
PF00621(RhoGEF)PF13426(PAS_9)PF16652(PH_13) | 6 | VAL B1321ASN B1354CYH B1355ARG B1356GLN B1359GLN B1418 | NoneFMN B1801 (-3.0A)FMN B1801 (-3.5A)FMN B1801 (-3.9A)FMN B1801 (-3.0A)FMN B1801 (-3.7A) | 0.94A | 4kukA-5hzkB:17.9 | 4kukA-5hzkB:16.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j3w | SENSORY BOX PROTEIN (Pseudomonasputida) |
PF13426(PAS_9) | 9 | VAL A 19CYH A 53ARG A 54GLN A 57ASN A 85ASN A 95LEU A 97ILE A 99GLN A 116 | NoneFMN A 500 (-3.6A)FMN A 500 (-3.5A)FMN A 500 (-4.0A)FMN A 500 (-3.0A)FMN A 500 (-4.3A)FMN A 500 (-4.2A)FMN A 500 (-4.3A)FMN A 500 (-4.5A) | 0.64A | 4kukA-5j3wA:16.2 | 4kukA-5j3wA:30.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lmx | DNA-DIRECTED RNAPOLYMERASES I ANDIII SUBUNITRPAC1,DNA-DIRECTEDRNA POLYMERASES IAND III SUBUNITRPAC1 (Saccharomycescerevisiae) |
PF01000(RNA_pol_A_bac)PF01193(RNA_pol_L) | 5 | VAL C 162ASN C 137ASN C 88LEU C 97ILE C 101 | VAL C 162 ( 0.6A)ASN C 137 ( 0.6A)ASN C 88 ( 0.6A)LEU C 97 ( 0.5A)ILE C 101 ( 0.6A) | 1.34A | 4kukA-5lmxC:undetectable | 4kukA-5lmxC:16.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5svw | ADAGIO PROTEIN 1 (Arabidopsisthaliana) |
no annotation | 5 | ARG B 55GLN B 58ASN B 95ASN B 105ILE B 20 | FMN B5201 (-3.8A)FMN B5201 (-3.1A)FMN B5201 (-2.4A)FMN B5201 (-3.8A)FMN B5201 (-2.9A) | 1.42A | 4kukA-5svwB:16.5 | 4kukA-5svwB:33.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5svw | ADAGIO PROTEIN 1 (Arabidopsisthaliana) |
no annotation | 8 | ASN B 53CYH B 54ARG B 55GLN B 58ASN B 95ASN B 105LEU B 107GLN B 126 | FMN B5201 (-2.9A)FMN B5201 (-3.3A)FMN B5201 (-3.8A)FMN B5201 (-3.1A)FMN B5201 (-2.4A)FMN B5201 (-3.8A)FMN B5201 ( 4.5A)FMN B5201 (-3.8A) | 0.86A | 4kukA-5svwB:16.5 | 4kukA-5svwB:33.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5svw | ADAGIO PROTEIN 1 (Arabidopsisthaliana) |
no annotation | 5 | ASN B 53CYH B 54ARG B 55LEU B 109ILE B 122 | FMN B5201 (-2.9A)FMN B5201 (-3.3A)FMN B5201 (-3.8A)FMN B5201 (-4.0A)FMN B5201 (-3.1A) | 0.98A | 4kukA-5svwB:16.5 | 4kukA-5svwB:33.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cr0 | (S)-6-HYDROXYNICOTINE OXIDASE (Shinella sp.HZN7) |
no annotation | 5 | ASN A 315ASN A 368LEU A 342ILE A 340GLN A 337 | None | 1.42A | 4kukA-6cr0A:undetectable | 4kukA-6cr0A:24.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fml | INO80 (Chaetomiumthermophilum) |
no annotation | 5 | ASN G 992CYH G1128ARG G1129GLN G1102ILE G1105 | None | 1.39A | 4kukA-6fmlG:undetectable | 4kukA-6fmlG:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbv | PUTATIVE BLUE-LIGHTPHOTORECEPTOR (Dinoroseobactershibae) |
no annotation | 5 | ASN A 47ASN A 71CYH A 72ASN A 104ILE A 88 | FMN A 500 ( 3.7A)FMN A 500 ( 3.2A)FMN A 500 (-3.7A)FMN A 500 (-3.0A)FMN A 500 (-4.1A) | 1.47A | 4kukA-6gbvA:25.8 | 4kukA-6gbvA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbv | PUTATIVE BLUE-LIGHTPHOTORECEPTOR (Dinoroseobactershibae) |
no annotation | 7 | VAL A 38SER A 40ASN A 47ASN A 71ARG A 73GLN A 76ASN A 104 | FMN A 500 (-4.8A)FMN A 500 (-3.1A)FMN A 500 ( 3.7A)FMN A 500 ( 3.2A)FMN A 500 (-4.5A)FMN A 500 (-4.2A)FMN A 500 (-3.0A) | 0.84A | 4kukA-6gbvA:25.8 | 4kukA-6gbvA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbv | PUTATIVE BLUE-LIGHTPHOTORECEPTOR (Dinoroseobactershibae) |
no annotation | 11 | VAL A 38SER A 40ASN A 47ASN A 71CYH A 72ARG A 73ASN A 104ASN A 114LEU A 116ILE A 118GLN A 135 | FMN A 500 (-4.8A)FMN A 500 (-3.1A)FMN A 500 ( 3.7A)FMN A 500 ( 3.2A)FMN A 500 (-3.7A)FMN A 500 (-4.5A)FMN A 500 (-3.0A)FMN A 500 (-4.0A)FMN A 500 (-4.1A)NoneFMN A 500 (-3.8A) | 0.66A | 4kukA-6gbvA:25.8 | 4kukA-6gbvA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbv | PUTATIVE BLUE-LIGHTPHOTORECEPTOR (Dinoroseobactershibae) |
no annotation | 6 | VAL A 38SER A 40ASN A 47ASN A 71CYH A 72ASN A 104 | FMN A 500 (-4.8A)FMN A 500 (-3.1A)FMN A 500 ( 3.7A)FMN A 500 ( 3.2A)FMN A 500 (-3.7A)FMN A 500 (-3.0A) | 1.12A | 4kukA-6gbvA:25.8 | 4kukA-6gbvA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 12as | ASPARAGINESYNTHETASE (Escherichiacoli) |
PF03590(AsnA) | 5 | ILE A 140ARG A 26LEU A 27ILE A 236GLY A 292 | None | 1.06A | 4kukA-12asA:undetectable | 4kukA-12asA:17.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1byw | PROTEIN (HUMAN ERGPOTASSIUM CHANNEL) (Homo sapiens) |
PF13426(PAS_9) | 5 | LEU A 69ILE A 82LEU A 86ILE A 96PHE A 125 | None | 0.63A | 4kukA-1bywA:17.6 | 4kukA-1bywA:29.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1cqi | PROTEIN(SUCCINYL-COASYNTHETASE BETACHAIN) (Escherichiacoli) |
PF00549(Ligase_CoA)PF08442(ATP-grasp_2) | 5 | VAL B 263ILE B 318ARG B 348LEU B 349GLY B 331 | None | 1.12A | 4kukA-1cqiB:undetectable | 4kukA-1cqiB:19.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ipk | BETA-CONGLYCININ,BETA CHAIN (Glycine max) |
PF00190(Cupin_1)PF07883(Cupin_2) | 5 | VAL A 52ILE A 51ARG A 50ILE A 123GLY A 339 | None | 1.04A | 4kukA-1ipkA:undetectable | 4kukA-1ipkA:15.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jnu | PHY3 PROTEIN (Adiantumcapillus-veneris) |
PF13426(PAS_9) | 5 | LEU A 969VAL A 979ILE A 982PHE A1025GLY A1027 | FMN A1033 (-4.1A)FMN A1033 ( 4.9A)FMN A1033 (-4.3A)FMN A1033 ( 4.6A)FMN A1033 (-3.7A) | 0.41A | 4kukA-1jnuA:19.4 | 4kukA-1jnuA:34.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n9l | PUTATIVE BLUE LIGHTRECEPTOR (Chlamydomonasreinhardtii) |
PF13426(PAS_9) | 5 | LEU A 60VAL A 70ILE A 73PHE A 116GLY A 118 | FMN A 500 (-4.3A)FMN A 500 (-4.3A)FMN A 500 ( 4.2A)FMN A 500 (-4.8A)FMN A 500 (-3.9A) | 0.34A | 4kukA-1n9lA:18.9 | 4kukA-1n9lA:36.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qc5 | PROTEIN (ALPHA1BETA1 INTEGRIN) (Homo sapiens) |
PF00092(VWA) | 5 | VAL B 336ILE B 335LEU B 333ILE B 337GLY B 518 | None | 1.04A | 4kukA-1qc5B:undetectable | 4kukA-1qc5B:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1r6b | CLPA PROTEIN (Escherichiacoli) |
PF00004(AAA)PF02861(Clp_N)PF07724(AAA_2)PF10431(ClpB_D2-small) | 5 | VAL X 318ILE X 319LEU X 212ILE X 281GLY X 226 | None | 1.11A | 4kukA-1r6bX:undetectable | 4kukA-1r6bX:11.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rqg | METHIONYL-TRNASYNTHETASE (Pyrococcusabyssi) |
PF08264(Anticodon_1)PF09334(tRNA-synt_1g) | 5 | MET A 460LEU A 508ILE A 515PHE A 403GLY A 401 | None | 0.92A | 4kukA-1rqgA:undetectable | 4kukA-1rqgA:11.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t0b | THUA-LIKE PROTEIN (Geobacillusstearothermophilus) |
PF06283(ThuA) | 5 | VAL A 218ILE A 98LEU A 97ILE A 214GLY A 103 | None | 1.09A | 4kukA-1t0bA:undetectable | 4kukA-1t0bA:19.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vq0 | 33 KDA CHAPERONIN (Thermotogamaritima) |
PF01430(HSP33) | 5 | LEU A 40VAL A 104ILE A 108LEU A 131ILE A 70 | None | 1.05A | 4kukA-1vq0A:undetectable | 4kukA-1vq0A:16.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1x3l | HYPOTHETICAL PROTEINPH0495 (Pyrococcushorikoshii) |
PF05161(MOFRL)PF13660(DUF4147) | 5 | VAL A 169ILE A 173ARG A 170ILE A 241GLY A 143 | NoneNoneNoneNoneEDO A 503 (-3.7A) | 1.02A | 4kukA-1x3lA:undetectable | 4kukA-1x3lA:14.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zl6 | BOTULINUM NEUROTOXINTYPE E (Clostridiumbotulinum) |
PF01742(Peptidase_M27) | 5 | LEU A 359ILE A 89ILE A 85PHE A 342GLY A 373 | None | 1.03A | 4kukA-1zl6A:undetectable | 4kukA-1zl6A:14.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2avd | CATECHOL-O-METHYLTRANSFERASE (Homo sapiens) |
PF01596(Methyltransf_3) | 5 | MET A 86LEU A 120ILE A 156PHE A 112GLY A 110 | SAM A 501 (-4.2A)NoneNoneSAM A 501 (-4.7A)SAM A 501 (-3.4A) | 1.10A | 4kukA-2avdA:undetectable | 4kukA-2avdA:19.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b2x | INTEGRIN ALPHA-1 (Rattusnorvegicus) |
PF00092(VWA) | 5 | VAL A 150ILE A 149LEU A 147ILE A 151GLY A 332 | None | 1.08A | 4kukA-2b2xA:undetectable | 4kukA-2b2xA:21.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dch | PUTATIVE HOMINGENDONUCLEASE (Thermoproteus) |
PF14528(LAGLIDADG_3) | 5 | VAL X 37ILE X 36LEU X 7ILE X 33GLY X 15 | None | 1.12A | 4kukA-2dchX:undetectable | 4kukA-2dchX:23.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gd2 | PROBABLEALPHA-METHYLACYL-COARACEMASE MCR (Mycobacteriumtuberculosis) |
PF02515(CoA_transf_3) | 5 | VAL A 57ILE A 36ARG A 35LEU A 13ILE A 351 | None | 1.08A | 4kukA-2gd2A:undetectable | 4kukA-2gd2A:19.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hru | PHOSPHORIBOSYLFORMYLGLYCINAMIDINESYNTHASE II (Thermotogamaritima) |
PF00586(AIRS)PF02769(AIRS_C)PF16904(PurL_C) | 5 | LEU A 153VAL A 88ILE A 92ILE A 91GLY A 156 | None | 1.06A | 4kukA-2hruA:undetectable | 4kukA-2hruA:13.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mwg | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF01740(STAS)PF13426(PAS_9) | 6 | LEU A 65ILE A 78ARG A 79LEU A 82ILE A 92GLY A 121 | FMN A 900 ( 4.1A)FMN A 900 ( 4.7A)NoneFMN A 900 ( 4.8A)FMN A 900 ( 4.1A)FMN A 900 (-2.9A) | 1.17A | 4kukA-2mwgA:14.8 | 4kukA-2mwgA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mwg | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF01740(STAS)PF13426(PAS_9) | 7 | LEU A 65VAL A 75ILE A 78LEU A 82ILE A 92PHE A 119GLY A 121 | FMN A 900 ( 4.1A)NoneFMN A 900 ( 4.7A)FMN A 900 ( 4.8A)FMN A 900 ( 4.1A)NoneFMN A 900 (-2.9A) | 0.78A | 4kukA-2mwgA:14.8 | 4kukA-2mwgA:22.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pr5 | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF13426(PAS_9) | 7 | LEU A 65VAL A 75ILE A 78LEU A 82ILE A 92PHE A 119GLY A 121 | FMN A 500 (-4.4A)FMN A 500 (-4.6A)FMN A 500 (-4.1A)FMN A 500 (-4.5A)FMN A 500 ( 4.6A)FMN A 500 ( 4.8A)FMN A 500 (-3.9A) | 0.24A | 4kukA-2pr5A:17.1 | 4kukA-2pr5A:33.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q2v | BETA-D-HYDROXYBUTYRATE DEHYDROGENASE (Pseudomonasputida) |
PF00106(adh_short) | 5 | LEU A 232VAL A 85ILE A 135ILE A 83GLY A 239 | None | 1.04A | 4kukA-2q2vA:undetectable | 4kukA-2q2vA:17.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2v4y | URIDYLATE KINASE (Escherichiacoli) |
PF00696(AA_kinase) | 5 | LEU A 47VAL A 51ILE A 12LEU A 162GLY A 232 | None | 1.05A | 4kukA-2v4yA:undetectable | 4kukA-2v4yA:21.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w40 | GLYCEROL KINASE,PUTATIVE (Plasmodiumfalciparum) |
PF00370(FGGY_N)PF02782(FGGY_C) | 5 | LEU A 144ILE A 208LEU A 190ILE A 155GLY A 163 | NoneNoneNoneNoneEDO A1510 (-3.4A) | 1.01A | 4kukA-2w40A:undetectable | 4kukA-2w40A:12.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wkp | NPH1-1, RAS-RELATEDC3 BOTULINUM TOXINSUBSTRATE 1 (Avena sativa;Homo sapiens) |
PF00071(Ras)PF13426(PAS_9) | 5 | LEU A 453VAL A 463ILE A 466PHE A 509GLY A 511 | FMN A1725 (-4.2A)FMN A1725 (-4.6A)FMN A1725 (-4.2A)NoneFMN A1725 (-3.7A) | 0.38A | 4kukA-2wkpA:18.0 | 4kukA-2wkpA:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xdf | PHOSPHOENOLPYRUVATE-PROTEINPHOSPHOTRANSFERASE (Escherichiacoli) |
PF00391(PEP-utilizers)PF02896(PEP-utilizers_C)PF05524(PEP-utilisers_N) | 5 | VAL A 481ILE A 485LEU A 515PHE A 523GLY A 500 | None | 1.09A | 4kukA-2xdfA:undetectable | 4kukA-2xdfA:12.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z6c | PHOTOTROPIN-1 (Arabidopsisthaliana) |
PF13426(PAS_9) | 6 | LEU A 237ILE A 250LEU A 254ILE A 264PHE A 293GLY A 295 | FMN A 500 (-4.4A)FMN A 500 (-4.1A)FMN A 500 (-4.7A)NoneNoneFMN A 500 (-3.9A) | 0.65A | 4kukA-2z6cA:16.6 | 4kukA-2z6cA:38.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z6d | PHOTOTROPIN-2 (Arabidopsisthaliana) |
PF13426(PAS_9) | 5 | LEU A 173VAL A 183ILE A 186PHE A 229GLY A 231 | FMN A 500 ( 4.4A)FMN A 500 ( 4.4A)FMN A 500 (-4.1A)FMN A 500 ( 4.5A)FMN A 500 (-3.7A) | 0.27A | 4kukA-2z6dA:19.1 | 4kukA-2z6dA:36.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zqq | METHYLGLUTACONYL-COAHYDRATASE (Homo sapiens) |
PF00378(ECH_1) | 5 | LEU A 118VAL A 164LEU A 107ILE A 168GLY A 93 | None | 1.12A | 4kukA-2zqqA:undetectable | 4kukA-2zqqA:18.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3akk | CTKA (Helicobacterpylori) |
PF07804(HipA_C) | 5 | LEU A 150ILE A 207ARG A 206LEU A 203ILE A 282 | None | 1.02A | 4kukA-3akkA:undetectable | 4kukA-3akkA:17.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3axx | 458AA LONGHYPOTHETICALENDO-1,4-BETA-GLUCANASE (Pyrococcushorikoshii) |
PF00150(Cellulase) | 5 | VAL A 66ILE A 101ARG A 102ILE A 93GLY A 144 | None | 1.11A | 4kukA-3axxA:undetectable | 4kukA-3axxA:12.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dt8 | BRAINPLATELET-ACTIVATINGFACTORACETYLHYDROLASE IBSUBUNIT ALPHA (Bos taurus) |
PF13472(Lipase_GDSL_2) | 5 | LEU A 136VAL A 121ILE A 120LEU A 84ILE A 117 | None | 1.11A | 4kukA-3dt8A:undetectable | 4kukA-3dt8A:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3few | COLICIN S4 (Escherichiacoli) |
PF01024(Colicin) | 5 | LEU X 453VAL X 313ILE X 314ILE X 317GLY X 479 | None | 0.91A | 4kukA-3fewX:undetectable | 4kukA-3fewX:15.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ial | PROLYL-TRNASYNTHETASE (Giardiaintestinalis) |
PF00587(tRNA-synt_2b)PF03129(HGTP_anticodon)PF09180(ProRS-C_1) | 5 | MET A 56ILE A 321LEU A 317ILE A 85GLY A 78 | None | 1.03A | 4kukA-3ialA:undetectable | 4kukA-3ialA:13.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3inn | PANTOTHENATESYNTHETASE (Brucellamelitensis) |
PF02569(Pantoate_ligase) | 6 | LEU A 212VAL A 263ILE A 261ARG A 245LEU A 253ILE A 280 | None | 1.42A | 4kukA-3innA:undetectable | 4kukA-3innA:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kbe | SUPEROXIDE DISMUTASE[CU-ZN] (Caenorhabditiselegans) |
PF00080(Sod_Cu) | 5 | LEU A 98ILE A 34LEU A 37ILE A 17GLY A 43 | None | 0.99A | 4kukA-3kbeA:undetectable | 4kukA-3kbeA:20.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l4g | PHENYLALANYL-TRNASYNTHETASE BETACHAIN (Homo sapiens) |
PF03483(B3_4)PF03484(B5) | 5 | LEU B 77VAL B 67ARG B 71ILE B 65PHE B 87 | None | 1.08A | 4kukA-3l4gB:undetectable | 4kukA-3l4gB:13.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ll8 | SERINE/THREONINE-PROTEIN PHOSPHATASE 2BCATALYTIC SUBUNITALPHA ISOFORM (Homo sapiens) |
PF00149(Metallophos) | 5 | MET A 191ILE A 305ARG A 279LEU A 116ILE A 331 | None | 0.83A | 4kukA-3ll8A:undetectable | 4kukA-3ll8A:18.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mw2 | NEUREXIN-1-ALPHA (Mus musculus) |
PF02210(Laminin_G_2) | 5 | VAL A 268LEU A 258ILE A 279PHE A 254GLY A 94 | None | 0.91A | 4kukA-3mw2A:undetectable | 4kukA-3mw2A:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mw4 | NEUREXIN-2-BETA (Mus musculus) |
PF02210(Laminin_G_2) | 6 | LEU A 95VAL A 236LEU A 226ILE A 247PHE A 222GLY A 92 | None | 1.16A | 4kukA-3mw4A:undetectable | 4kukA-3mw4A:20.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ncy | ADIC (Salmonellaenterica) |
PF13520(AA_permease_2) | 5 | LEU A 388VAL A 59LEU A 66ILE A 390GLY A 381 | None | 1.11A | 4kukA-3ncyA:undetectable | 4kukA-3ncyA:14.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3onp | TRNA/RRNAMETHYLTRANSFERASE(SPOU) (Rhodobactersphaeroides) |
PF00588(SpoU_methylase) | 5 | VAL A 36ILE A 35ARG A 34LEU A 33GLY A 19 | NoneNoneBME A 254 (-3.3A)NoneNone | 0.92A | 4kukA-3onpA:undetectable | 4kukA-3onpA:19.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p7n | SENSOR HISTIDINEKINASE (Erythrobacterlitoralis) |
PF00196(GerE)PF13426(PAS_9) | 5 | LEU A 78ILE A 91ILE A 105PHE A 134GLY A 136 | FMN A 500 (-4.6A)FMN A 500 (-3.9A)FMN A 500 (-4.1A)NoneFMN A 500 ( 4.0A) | 0.38A | 4kukA-3p7nA:19.3 | 4kukA-3p7nA:29.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qcw | NEUREXIN-1-ALPHA (Bos taurus) |
PF00008(EGF)PF02210(Laminin_G_2) | 5 | VAL A1314LEU A1304ILE A1325PHE A1300GLY A1140 | None | 0.94A | 4kukA-3qcwA:undetectable | 4kukA-3qcwA:8.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r9p | ACKA (Mycobacteriumavium) |
PF00871(Acetate_kinase) | 6 | LEU A 338VAL A 366ILE A 314ARG A 328LEU A 196ILE A 364 | NoneNoneNoneGOL A 388 ( 4.2A)NoneNone | 1.16A | 4kukA-3r9pA:undetectable | 4kukA-3r9pA:17.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ryt | PLEXIN-A1 (Mus musculus) |
PF08337(Plexin_cytopl) | 5 | LEU A1720ILE A1713LEU A1447ILE A1818PHE A1747 | None | 1.10A | 4kukA-3rytA:undetectable | 4kukA-3rytA:14.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sun | DNA POLYMERASE (Escherichiavirus RB69) |
PF00136(DNA_pol_B)PF03104(DNA_pol_B_exo1) | 5 | VAL A 110ILE A 212LEU A 271ILE A 108GLY A 348 | None | 1.07A | 4kukA-3sunA:undetectable | 4kukA-3sunA:9.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t50 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE (Brucellamelitensis) |
PF13426(PAS_9) | 5 | LEU A 72VAL A 82ILE A 85ILE A 99PHE A 128 | FMN A 200 (-4.3A)FMN A 200 (-4.3A)FMN A 200 (-4.2A)FMN A 200 ( 4.4A)FMN A 200 (-4.5A) | 0.24A | 4kukA-3t50A:19.5 | 4kukA-3t50A:39.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tb6 | ARABINOSE METABOLISMTRANSCRIPTIONALREPRESSOR (Bacillussubtilis) |
PF13377(Peripla_BP_3) | 5 | LEU A 85ILE A 101LEU A 105ILE A 169GLY A 138 | None | 1.11A | 4kukA-3tb6A:undetectable | 4kukA-3tb6A:17.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w6m | 458AA LONGHYPOTHETICALENDO-1,4-BETA-GLUCANASE (Pyrococcushorikoshii) |
PF00150(Cellulase) | 5 | VAL A 66ILE A 101ARG A 102ILE A 93GLY A 144 | None | 1.12A | 4kukA-3w6mA:undetectable | 4kukA-3w6mA:17.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w9i | MULTIDRUG RESISTANCEPROTEIN MEXB (Pseudomonasaeruginosa) |
PF00873(ACR_tran) | 5 | VAL A 172ILE A 291ILE A 306PHE A 178GLY A 141 | None | 0.99A | 4kukA-3w9iA:undetectable | 4kukA-3w9iA:8.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wfo | POLY A POLYMERASE (Aquifexaeolicus) |
PF01743(PolyA_pol)PF01966(HD)PF12627(PolyA_pol_RNAbd) | 5 | MET A 231VAL A 353ILE A 356LEU A 360ILE A 327 | None | 1.07A | 4kukA-3wfoA:undetectable | 4kukA-3wfoA:16.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wfp | POLY A POLYMERASE (Aquifexaeolicus;syntheticconstruct) |
PF01743(PolyA_pol)PF01966(HD)PF12627(PolyA_pol_RNAbd) | 5 | MET A 231VAL A 353ILE A 356LEU A 360ILE A 327 | None | 1.06A | 4kukA-3wfpA:undetectable | 4kukA-3wfpA:17.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4abk | POLY [ADP-RIBOSE]POLYMERASE 14 (Homo sapiens) |
PF01661(Macro) | 5 | VAL A1258ILE A1262LEU A1263ILE A1236GLY A1290 | AR6 A2389 (-3.9A)NoneNoneAR6 A2389 (-3.9A)None | 1.11A | 4kukA-4abkA:undetectable | 4kukA-4abkA:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4d82 | AAA ATPASE, CENTRALDOMAIN PROTEIN (Metallosphaerasedula) |
PF00004(AAA)PF09336(Vps4_C) | 5 | LEU A 278VAL A 313ILE A 312LEU A 344GLY A 303 | None | 1.09A | 4kukA-4d82A:undetectable | 4kukA-4d82A:21.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ees | PHOTOTROPIN-2 (Arabidopsisthaliana) |
PF13426(PAS_9) | 5 | LEU A 429VAL A 439ILE A 442PHE A 485GLY A 487 | FMN A1001 (-4.2A)FMN A1001 (-4.5A)FMN A1001 (-4.1A)FMN A1001 (-4.6A)FMN A1001 (-3.8A) | 0.26A | 4kukA-4eesA:20.2 | 4kukA-4eesA:34.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4f3e | CASA (Thermusthermophilus) |
PF09481(CRISPR_Cse1) | 5 | LEU A 32VAL A 17ILE A 41ARG A 40ILE A 15 | None | 1.11A | 4kukA-4f3eA:undetectable | 4kukA-4f3eA:15.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gcz | BLUE-LIGHTPHOTORECEPTOR,SENSOR PROTEIN FIXL (Bacillussubtilis;Bradyrhizobiumdiazoefficiens) |
PF00512(HisKA)PF02518(HATPase_c)PF13426(PAS_9) | 7 | LEU A 65VAL A 75ILE A 78LEU A 82ILE A 92PHE A 119GLY A 121 | FMN A 401 (-4.5A)FMN A 401 ( 4.6A)FMN A 401 (-4.1A)FMN A 401 (-4.5A)FMN A 401 ( 4.6A)FMN A 401 (-4.7A)FMN A 401 (-3.7A) | 0.40A | 4kukA-4gczA:17.7 | 4kukA-4gczA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h08 | PUTATIVE HYDROLASE (Bacteroidesthetaiotaomicron) |
PF00657(Lipase_GDSL) | 5 | VAL A 216ILE A 217LEU A 65ILE A 138GLY A 72 | None | 1.13A | 4kukA-4h08A:undetectable | 4kukA-4h08A:22.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h0o | ACETATE KINASE (Entamoebahistolytica) |
PF00871(Acetate_kinase) | 5 | VAL A 331ILE A 335LEU A 318ILE A 298GLY A 306 | None | 0.76A | 4kukA-4h0oA:undetectable | 4kukA-4h0oA:14.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hhd | PHOTOTROPIN-1 (Arabidopsisthaliana) |
PF13426(PAS_9) | 6 | LEU A 515VAL A 525ILE A 528ARG A 529PHE A 571GLY A 573 | FMN A 701 (-4.4A)FMN A 701 (-4.9A)FMN A 701 ( 4.1A)NoneFMN A 701 (-4.9A)FMN A 701 (-3.7A) | 0.80A | 4kukA-4hhdA:19.2 | 4kukA-4hhdA:32.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hj3 | LOV PROTEIN (Rhodobactersphaeroides) |
PF13426(PAS_9) | 5 | LEU A 58ILE A 71LEU A 75PHE A 114GLY A 116 | FMN A 201 (-4.4A)FMN A 201 ( 4.0A)FMN A 201 ( 4.7A)NoneFMN A 201 (-3.9A) | 0.94A | 4kukA-4hj3A:15.0 | 4kukA-4hj3A:29.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4i3h | TOPOISOMERASE IVSUBUNIT B, DNATOPOISOMERASE 4SUBUNIT A CHIMERA (Streptococcuspneumoniae) |
PF00204(DNA_gyraseB)PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)PF02518(HATPase_c) | 5 | VAL A1343ILE A1342LEU A1163ILE A1201GLY A1210 | None | 1.09A | 4kukA-4i3hA:undetectable | 4kukA-4i3hA:8.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ijn | ACETATE KINASE (Mycolicibacteriumsmegmatis) |
PF00871(Acetate_kinase) | 5 | LEU A 330VAL A 358ILE A 306ARG A 320LEU A 188 | None | 1.09A | 4kukA-4ijnA:undetectable | 4kukA-4ijnA:18.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4il1 | CALMODULIN,CALCINEURIN SUBUNITB TYPE 1,SERINE/THREONINE-PROTEIN PHOSPHATASE 2BCATALYTIC SUBUNITALPHA ISOFORM (Rattusnorvegicus) |
PF00149(Metallophos)PF13499(EF-hand_7) | 5 | MET A 524ILE A 638ARG A 612LEU A 449ILE A 664 | None | 1.00A | 4kukA-4il1A:undetectable | 4kukA-4il1A:11.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ln1 | L-LACTATEDEHYDROGENASE 1 (Bacillus cereus) |
PF00056(Ldh_1_N)PF02866(Ldh_1_C) | 5 | VAL A 243ILE A 247LEU A 248ILE A 144GLY A 116 | None | 1.11A | 4kukA-4ln1A:undetectable | 4kukA-4ln1A:18.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4m2g | L-ARGININEBETA-HYDROXYLASE (Streptomyceslavendulae) |
PF02668(TauD) | 5 | LEU A 113VAL A 293ILE A 74LEU A 14GLY A 55 | None | 1.01A | 4kukA-4m2gA:undetectable | 4kukA-4m2gA:18.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4orb | SERINE/THREONINE-PROTEIN PHOSPHATASE 2BCATALYTIC SUBUNITALPHA ISOFORM (Mus musculus) |
PF00149(Metallophos) | 5 | MET A 191ILE A 305ARG A 279LEU A 116ILE A 331 | None | 0.85A | 4kukA-4orbA:undetectable | 4kukA-4orbA:15.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ox2 | PHOSPHOENOLPYRUVATECARBOXYKINASE,CYTOSOLIC [GTP] (Rattusnorvegicus) |
PF00821(PEPCK_C)PF17297(PEPCK_N) | 5 | LEU A 300VAL A 305ILE A 270LEU A 280GLY A 542 | None | 0.98A | 4kukA-4ox2A:undetectable | 4kukA-4ox2A:12.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4p52 | HOMOSERINE KINASE (Cytophagahutchinsonii) |
PF00288(GHMP_kinases_N)PF08544(GHMP_kinases_C) | 5 | LEU A 70VAL A 107ILE A 110LEU A 114GLY A 81 | None | 0.98A | 4kukA-4p52A:undetectable | 4kukA-4p52A:16.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4pyr | PUTATIVEBRANCHED-CHAIN AMINOACID ABC TRANSPORTER (Chromobacteriumviolaceum) |
PF04348(LppC) | 5 | VAL A 145ILE A 146LEU A 168ILE A 86GLY A 107 | None | 1.06A | 4kukA-4pyrA:undetectable | 4kukA-4pyrA:16.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qez | 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE (Bacillusanthracis) |
no annotation | 5 | ARG B 96LEU B 169ILE B 192PHE B 80GLY B 78 | NoneNoneNoneNoneADE B 301 (-3.2A) | 1.08A | 4kukA-4qezB:undetectable | 4kukA-4qezB:22.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF13426(PAS_9) | 5 | LEU A 58VAL A 68ILE A 85PHE A 114GLY A 116 | RBF A 201 (-3.9A)RBF A 201 (-3.3A)RBF A 201 ( 4.2A)RBF A 201 (-4.4A)RBF A 201 ( 3.3A) | 0.58A | 4kukA-4r38A:18.4 | 4kukA-4r38A:36.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF07568(HisKA_2)PF13426(PAS_9)PF13581(HATPase_c_2) | 5 | LEU A 58VAL A 68ILE A 85PHE A 114GLY A 116 | RBF A 402 (-4.2A)RBF A 402 (-3.5A)RBF A 402 (-4.0A)RBF A 402 ( 4.3A)RBF A 402 ( 3.8A) | 0.42A | 4kukA-4r3aA:14.6 | 4kukA-4r3aA:16.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r3u | 2-HYDROXYISOBUTYRYL-COA MUTASE LARGESUBUNIT (Aquincolatertiaricarbonis) |
PF01642(MM_CoA_mutase) | 5 | LEU A 264VAL A 222ILE A 226ARG A 223ILE A 239 | None | 1.07A | 4kukA-4r3uA:undetectable | 4kukA-4r3uA:13.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uar | PROTEIN CBBY (Rhodobactersphaeroides) |
PF13419(HAD_2) | 5 | ILE A 5LEU A 174ILE A 109PHE A 214GLY A 219 | None | 1.11A | 4kukA-4uarA:undetectable | 4kukA-4uarA:20.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ufc | GH95 (Bacteroidesovatus) |
PF14498(Glyco_hyd_65N_2) | 5 | LEU A 694ILE A 741ARG A 740LEU A 739PHE A 715 | None | 0.94A | 4kukA-4ufcA:undetectable | 4kukA-4ufcA:9.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4w8o | LUCIFERASE-LIKEENZYMEAMP-COA-LIGASE (Zophobasatratus) |
PF00501(AMP-binding) | 5 | LEU A 87VAL A 58ARG A 57PHE A 25GLY A 21 | None | 1.10A | 4kukA-4w8oA:undetectable | 4kukA-4w8oA:14.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wed | ABC TRANSPORTER,PERIPLASMICSOLUTE-BINDINGPROTEIN (Sinorhizobiummeliloti) |
PF00496(SBP_bac_5) | 5 | VAL A 384ILE A 385LEU A 396ILE A 305GLY A 418 | None | 1.01A | 4kukA-4wedA:undetectable | 4kukA-4wedA:14.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wfs | TRNA-DIHYDROURIDINE(20) SYNTHASE[NAD(P)+]-LIKE (Homo sapiens) |
PF01207(Dus) | 5 | VAL A 182ILE A 156ARG A 157LEU A 131ILE A 180 | NoneNoneSO4 A 403 (-4.2A)NoneNone | 0.96A | 4kukA-4wfsA:undetectable | 4kukA-4wfsA:18.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xq7 | 2'-5'-OLIGOADENYLATESYNTHASE-LIKEPROTEIN (Homo sapiens) |
PF10421(OAS1_C) | 5 | LEU A 34ILE A 140LEU A 118ILE A 149PHE A 43 | None | 1.08A | 4kukA-4xq7A:undetectable | 4kukA-4xq7A:18.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zk3 | SERPIN B3 (Homo sapiens) |
PF00079(Serpin) | 5 | LEU A 42LEU A 174ILE A 307PHE A 115GLY A 316 | None | 1.07A | 4kukA-4zk3A:undetectable | 4kukA-4zk3A:15.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zkt | BONTOXILYSIN A (Clostridiumbotulinum) |
PF01742(Peptidase_M27)PF07951(Toxin_R_bind_C)PF07952(Toxin_trans)PF07953(Toxin_R_bind_N) | 5 | LEU A 360ILE A 90ILE A 86PHE A 343GLY A 374 | None | 1.11A | 4kukA-4zktA:undetectable | 4kukA-4zktA:7.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a8b | PTAUREO1A LOV2DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 5 | LEU A 290VAL A 300ILE A 303PHE A 346GLY A 348 | FMN A 500 (-4.0A)NoneFMN A 500 ( 4.1A)FMN A 500 (-4.8A)FMN A 500 (-3.8A) | 0.58A | 4kukA-5a8bA:19.3 | 4kukA-5a8bA:36.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dem | ACYL-[ACYL-CARRIER-PROTEIN]--UDP-N-ACETYLGLUCOSAMINEO-ACYLTRANSFERASE (Pseudomonasaeruginosa) |
PF00132(Hexapep)PF13720(Acetyltransf_11) | 5 | VAL A 92ILE A 88ARG A 89ILE A 94GLY A 83 | None | 1.05A | 4kukA-5demA:undetectable | 4kukA-5demA:17.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dju | NPH1-2 (Avena sativa) |
PF13426(PAS_9) | 6 | LEU A 453VAL A 463ILE A 466ARG A 467PHE A 509GLY A 511 | FMN A 601 (-4.0A)FMN A 601 (-4.6A)FMN A 601 ( 4.4A)NoneNoneFMN A 601 (-3.8A) | 0.82A | 4kukA-5djuA:17.3 | 4kukA-5djuA:30.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dkk | LOV DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 5 | LEU A 290VAL A 300ILE A 303PHE A 346GLY A 348 | FMN A 401 (-4.1A)FMN A 401 (-4.4A)FMN A 401 (-4.2A)FMN A 401 (-4.8A)FMN A 401 (-3.7A) | 0.53A | 4kukA-5dkkA:19.4 | 4kukA-5dkkA:36.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e4r | KETOL-ACIDREDUCTOISOMERASE (Ignisphaeraaggregans) |
PF01450(IlvC)PF07991(IlvN) | 5 | MET A 472VAL A 236ILE A 239ILE A 354GLY A 465 | None | 1.09A | 4kukA-5e4rA:undetectable | 4kukA-5e4rA:15.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hzh | RAS-RELATED C3BOTULINUM TOXINSUBSTRATE1,NPH1-1,RAS-RELATEDC3 BOTULINUM TOXINSUBSTRATE 1 (Avena sativa;Homo sapiens) |
PF00071(Ras)PF13426(PAS_9) | 5 | LEU A 100VAL A 110ILE A 113PHE A 156GLY A 158 | FMN A 402 (-4.1A)FMN A 402 (-4.5A)FMN A 402 (-4.3A)FMN A 402 (-4.9A)FMN A 402 (-3.7A) | 0.39A | 4kukA-5hzhA:17.7 | 4kukA-5hzhA:25.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hzk | INTERSECTIN-1,NPH1-1,INTERSECTIN-1 (Avena sativa;Homo sapiens) |
PF00621(RhoGEF)PF13426(PAS_9)PF16652(PH_13) | 5 | LEU B1358VAL B1368ILE B1371PHE B1414GLY B1416 | FMN B1801 (-4.2A)FMN B1801 (-4.5A)FMN B1801 (-4.1A)FMN B1801 (-4.8A)FMN B1801 (-3.7A) | 0.41A | 4kukA-5hzkB:17.9 | 4kukA-5hzkB:16.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lq3 | CMEB (Campylobacterjejuni) |
PF00873(ACR_tran) | 5 | VAL A 445ILE A 448LEU A 452ILE A 413GLY A 405 | None | 1.07A | 4kukA-5lq3A:undetectable | 4kukA-5lq3A:8.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mlc | 50S RIBOSOMALPROTEIN L21,CHLOROPLASTIC (Spinaciaoleracea) |
PF00829(Ribosomal_L21p) | 5 | VAL T 186ILE T 219ARG T 218ILE T 156GLY T 130 | NoneNoneNoneNone U A1188 ( 3.3A) | 1.05A | 4kukA-5mlcT:undetectable | 4kukA-5mlcT:17.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5n94 | CG9323, ISOFORM A (Drosophilamelanogaster) |
no annotation | 5 | LEU A 426VAL A 413ILE A 416ILE A 505GLY A 547 | None | 0.81A | 4kukA-5n94A:undetectable | 4kukA-5n94A:17.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5t77 | PUTATIVE LIPID IIFLIPPASE MURJ (Thermosiphoafricanus) |
PF03023(MVIN) | 5 | LEU A 156ILE A 163ILE A 160PHE A 23GLY A 21 | OLC A 527 ( 4.5A)NoneOLC A 527 ( 4.7A)OLC A 536 (-3.3A)None | 1.08A | 4kukA-5t77A:undetectable | 4kukA-5t77A:13.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uin | FORMYLTRANSFERASE (Salmonellaenterica) |
PF00551(Formyl_trans_N)PF13637(Ank_4) | 5 | MET A 348VAL A 308ILE A 320ILE A 330GLY A 356 | None | 1.08A | 4kukA-5uinA:undetectable | 4kukA-5uinA:14.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wbg | CYTOCHROME P450 2B6 (Homo sapiens) |
no annotation | 5 | LEU A 396VAL A 81ILE A 84LEU A 88GLY A 366 | NoneNoneNoneNoneHEM A 501 ( 4.5A) | 0.98A | 4kukA-5wbgA:undetectable | 4kukA-5wbgA:23.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x41 | COBALT TRANSPORTPROTEIN CBIM (Rhodobactercapsulatus) |
no annotation | 5 | VAL M 35ILE M 34ARG M 38ILE M 31GLY M 81 | None | 1.11A | 4kukA-5x41M:undetectable | 4kukA-5x41M:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xdr | PRE-MRNA-SPLICINGFACTOR ATP-DEPENDENTRNA HELICASE DHX15 (Homo sapiens) |
PF00270(DEAD)PF00271(Helicase_C)PF04408(HA2)PF07717(OB_NTP_bind) | 5 | LEU A 353VAL A 339ILE A 342ILE A 437GLY A 479 | None | 0.83A | 4kukA-5xdrA:undetectable | 4kukA-5xdrA:12.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fa5 | PUTATIVE MRNASPLICING FACTOR (Chaetomiumthermophilum) |
no annotation | 5 | LEU A 510VAL A 497ILE A 500ILE A 588GLY A 632 | None | 0.83A | 4kukA-6fa5A:undetectable | 4kukA-6fa5A:21.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbv | PUTATIVE BLUE-LIGHTPHOTORECEPTOR (Dinoroseobactershibae) |
no annotation | 8 | LEU A 75VAL A 85ILE A 88ARG A 89LEU A 92ILE A 102PHE A 131GLY A 133 | FMN A 500 (-4.0A)FMN A 500 (-4.3A)FMN A 500 (-4.1A)NoneFMN A 500 (-4.6A)FMN A 500 ( 4.3A)FMN A 500 (-4.8A)FMN A 500 (-3.9A) | 0.29A | 4kukA-6gbvA:25.8 | 4kukA-6gbvA:undetectable |